US11199552B2 - Assessing Susceptibility to Cardiac Intervention, Susceptibility to Therapy for Heart Failure, Risk of Mortality or Further Cardiovascular Events, and Risk of Subsequent Pulmonary Embolism in Relevant Patients Based on Determinations of GDF-15, Natriuretic Peptide, Cardiac Troponin or Combinations Thereof | Patent Bear